[1]
|
Foster, J.D. (2020) Extracorporeal Therapies in the Emergency Room and Intensive Care Unit. Veterinary Clinics of North America: Small Animal Practice, 50, 1215-1236. https://doi.org/10.1016/j.cvsm.2020.07.014
|
[2]
|
Ghannoum, M., Hoffman, R.S., Gosselin, S., et al. (2018) Use of Extracorporeal Treatments in the Management of Poisonings. Kidney International, 94, 682-688. https://doi.org/10.1016/j.kint.2018.03.026
|
[3]
|
Harm, S., Schildböck, C. and Hartmann, J. (2020) Cytokine Re-moval in Extracorporeal Blood Purification: An in Vitro Study. Blood Purification, 49, 33-43. https://doi.org/10.1159/000502680
|
[4]
|
Copelli, S., Lorenzin, A. and Ronco, C. (2023) Chemical-Physical Mecha-nisms of Adsorption for Blood Purification. Contributions to Nephrology, 200, 1-9.
|
[5]
|
Kaçar, C.K., Uzundere, O., Kandemir, D. and Yektaş, A. (2020) Efficacy of HA330 Hemoperfusion Adsorbent in Patients Followed in the Intensive Care Unit for Septic Shock and Acute Kidney Injury and Treated with Continuous Venovenous Hemodiafiltration as Re-nal Replacement Therapy. Blood Purification, 49, 448-456.
https://doi.org/10.1159/000505565
|
[6]
|
Ankawi, G., Fan, W., Pomarè Montin, D., et al. (2019) A New Series of Sorbent Devices for Multiple Clinical Purposes: Current Evidence and Future Directions. Blood Purification, 47, 94-100. https://doi.org/10.1159/000493523
|
[7]
|
Li, S. and Liang, Y. (2023) Effects of Hemoperfusion First Aid Process Reengineering on Electrolyte Disturbance, Liver Function and Prognosis in Patients with Acute Poisoning. Biotechnology and Genetic Engineering Reviews.
https://doi.org/10.1080/02648725.2023.2200326
|
[8]
|
Ronco, C. and Bellomo, R. (2022) Hemoperfusion: Tech-nical Aspects and State of the Art. Critical Care, 26, Article No. 135. https://doi.org/10.1186/s13054-022-04009-w
|
[9]
|
Shi, L., Yu, G., Li, Y., Zhao, L., Wen, Z., Tao, Y., Wang, W. and Jian, X. (2022) The Toxicokinetics of Acute Paraquat Poisoning in Specific Patients: A Case Series. Journal of In-ternational Medical Research, 50, Article ID: 3000605221122745. https://doi.org/10.1177/03000605221122745
|
[10]
|
Wolley, M., Jardine, M. and Hutchison, C.A. (2018) Exploring the Clinical Relevance of Providing Increased Removal of Large Middle Molecules. Clinical Journal of the American So-ciety of Nephrology, 13, 805-814.
https://doi.org/10.2215/CJN.10110917
|
[11]
|
Pomarè Montin, D., Ankawi, G., Lorenzin, A., et al. (2018) Biocom-patibility and Cytotoxic Evaluation of New Sorbent Cartridges for Blood Hemoperfusion. Blood Purification, 46, 187-195. https://doi.org/10.1159/000489921
|
[12]
|
Rommes, J.H., Sangster, B., Berrens, L., Borst, C. and van Heijst, A.N. (1986) Biocompatibility of Haemoperfusion. Archives of Toxicology, 58, 187-195. https://doi.org/10.1007/BF00340980
|
[13]
|
Jha, V.K. and Padmaprakash, K.V. (2018) Extracorporeal Treatment in the Management of Acute Poisoning: What an Intensivist Should Know? Indian Journal of Critical Care Medicine, 22, 862-869.
https://doi.org/10.4103/ijccm.IJCCM_425_18
|
[14]
|
Jansen, T., Hoegberg, L.C.G., Eriksen, T., et al. (2019) Ami-triptyline Accumulation in Tissues after Coated Activated Charcoal Hemoperfusion—A Randomized Controlled Animal Poisoning Model. Naunyn-Schmiedeberg’s Archives of Pharmacology, 392, 1285-1292. https://doi.org/10.1007/s00210-019-01669-4
|
[15]
|
Yeh, Y.-T., Chen, C.-K., Lin, C.-C., et al. (2020) Does Hemoperfusion Increase Survival in Acute Paraquat Poisoning? A Retrospective Multicenter Study. Toxics, 8, Article No. 84. https://doi.org/10.3390/toxics8040084
|
[16]
|
Liu, Y., Wang, Z.-K., Liu, C.-Z., Liu, Y.-Y., Li, Q., Wang, H., Cui, F., Zhang, D.-W. and Li, Z.-T. (2022) Supramolecular Organic Frameworks as Adsorbents for Efficient Removal of Ex-cess Bilirubin in Hemoperfusion. ACS Applied Materials & Interfaces, 14, 47397-47408. https://doi.org/10.1021/acsami.2c11458
|
[17]
|
Zhao, D., Wang, Y., Wang, Y., et al. (2022) Randomized Control Study on Hemoperfusion Combined with Hemodialysis versus Standard Hemodialysis: Effects on Mid-dle-Molecular-Weight Toxins and Uremic Pruritus. Blood Purification, 11, 1-11.
|
[18]
|
King, J.D., Kern, M.H. and Jaar, B.G. (2019) Extracorporeal Removal of Poisons and Toxins. Clinical Journal of the American Society of Nephrology, 14, 1408-1415. https://doi.org/10.2215/CJN.02560319
|
[19]
|
Hahn, R.G. (2020) Understanding Volume Kinetics. Acta Anaesthesiologica Scandinavica, 64, 570-578.
https://doi.org/10.1111/aas.13533
|
[20]
|
Alves, R.N., Rambla-Alegre, M., Braga, A.C., et al. (2019) Bioaccessibility of Lipophilic and Hydrophilic Marine Biotoxins in Seafood: An in Vitro Digestion Approach. Food and Chemical Toxi-cology, 129, 153-161.
https://doi.org/10.1016/j.fct.2019.04.041
|
[21]
|
Rey, S., Kulabukhov, V.M., Popov, A., Nikitina, O., Berdnikov, G., Magomedov, M., Kim, T., Masolitin, S., Ignatenko, O., Krotenko, N., Marysheva, A., Chaus, N., Ohinko, L., Mendibaev, M., Chumachenko, A. and Pisarev, V. (2023) Hemoperfusion Using the LPS-Selective Mesoporous Poly-meric Adsorbent in Septic Shock: A Multicenter Randomized Clinical Trial. Shock, 59, 846-854. https://doi.org/10.1097/SHK.0000000000002121
|
[22]
|
Florens, N., Yi, D., Juillard, L. and Soulage, C.O. (2018) Using Binding Competitors of Albumin to Promote the Removal of Protein-Bound Uremic Toxins in Hemodialysis: Hope or Pipe Dream? Biochimie, 144, 1-8.
https://doi.org/10.1016/j.biochi.2017.09.018
|
[23]
|
Dargent, A., Pais de Barros, J.-P., Saheb, S., et al. (2020) LDLApheresis as an Alternate Method for Plasma LPS Purification in Healthy Volunteers and Dyslipidemic and Septic Patients. Journal of Lipid Research, 61, 1776-1783.
https://doi.org/10.1194/jlr.RA120001132
|
[24]
|
Wen, Z., Li, X., Zhang, Y., Shi, J., Zhang, J., Zheng, Y., Lin, Y., Jian, T., Jian, X., Kan, B. and Luan, X. (2022) Comparing the Application of Three Thrombosis Risk Assessment Mod-els in Patients with Acute Poisoning: A Cross-Sectional Survey. Frontiers in Medicine, 9, Article 1072467. https://doi.org/10.3389/fmed.2022.1072467
|
[25]
|
Wang, G., Li, Z., Zhang, Y., Pan, Y. and Chen, L. (2021) Com-parison of Combined Hemodialysis and Hemoperfusion with Hemoperfusion Alone in 106 Patients with Diabetic Ke-toacidosis and Acute Renal Failure: A Retrospective Study from a Single Center in China. Medical Science Monitor, 27, e922753. https://doi.org/10.12659/MSM.922753
|
[26]
|
Ghannoum, M., Lavergne, V., Gosselin, S., et al. (2016) Practice Trends in the Use of Extracorporeal Treatments for Poisoning in Four Countries. Seminars in Dialysis, 29, 71-80. https://doi.org/10.1111/sdi.12448
|
[27]
|
Ronco, C., Chawla, L., Husain-Syed, F. and Kellum, J.A. (2023) Ra-tionale for Sequential Extracorporeal Therapy (SET) in Sepsis. Critical Care, 27, Article No. 50. https://doi.org/10.1186/s13054-023-04310-2
|
[28]
|
Yu, Y. and Ou, L. (2023) The Development of Immunosorbents for the Treatment of Systemic Lupus Erythematosus via Hemoperfusion. Frontiers in Medicine, 9, Article 1035150. https://doi.org/10.3389/fmed.2022.1035150
|
[29]
|
Fick, M.E., Messenger, K.M. and Vigani, A. (2020) Efficacy of a Single Session in-Series Hemoperfusion and Hemodialysis in the Management of Carprofen Overdose in Two Dogs. Journal of Veterinary Emergency and Critical Care, 30, 226-231. https://doi.org/10.1111/vec.12931
|
[30]
|
Li, J., Li, H., Deng, W., Meng, L., Gong, W. and Yao, H. (2022) The Effect of Combination Use of Hemodialysis and Hemoperfusion on Microinflammation in Elderly Patients with Maintenance Hemodialysis. Blood Purification, 51, 739-746. https://doi.org/10.1159/000518857
|